Inovio Pharmaceuticals, Inc.
NASDAQ:INO · NASDAQ Global Select
-$0.01 today
Vol 2.50M · Avg 2.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-42.23%
Period High
$2.87
Period Low
$1.05
Latest
$1.12
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$338.48M
Fate Therapeutics, Inc.
NASDAQ:FATE
$235.45M
Alector, Inc.
NASDAQ:ALEC
$184.86M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$139.22M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$128.83M
Agenus Inc.
NASDAQ:AGEN
$123.03M
Seer, Inc.
NASDAQ:SEER
$94.57M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$63.53M
Actuate Therapeutics Inc
NASDAQ:ACTU
$50.01M
VistaGen Therapeutics, Inc.
VTGN
$22.62M
What is the latest INO filing?
The latest filing shown is S-8 dated May 26, 2026.
How many recent filings does INO have?
Intrinsic Alpha currently shows 20 recent filings for INO.
Explore More
Continue the stock analysis
Jump to another research area for this company.